According to Future Market Insights research, during the projected period, the USA knotless surgical sutures market is expected to grow at a CAGR of 3.6%. The market value is projected to increase from USD 181.0 Million in 2023 to USD 258.7 Million by 2033. The USA knotless surgical sutures was valued at USD 175.7 Million at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 3.1% in 2023.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | USD 175.7 Million |
| Market Value 2023 | USD 181.0 Million |
| Market Value 2033 | USD 258.7 Million |
| CAGR 2023 to 2033 | 3.6% |
| Share of Top 5 Companies | 32.1% |
| Key Players | The key players in the knotless surgical sutures market are Medtronic; B. Braun Melsungen AG; Teleflex Incorporated; Johnson & Johnson (Ethicon); CONMED Corporation; Corza Medical; CP Medical; DemeTECH Corporation; Sutumed; DSI Dental Solution; Golnit Sutures; Vital Sutures; Atramat; Unilene; Advanced MedTech Solutions Pvt. Ltd; Dolphin Sutures; Arthrex; Inc; GMD Group; Dynek Pvt Ltd; Kono Seisakusho Co.;Ltd ); Olimp- Surgical Sutures; Lotus Surgicals; Unisur Lifecare Pvt Ltd. |
The knotless barbed suture is a monofilament suture specifically designed with barbs. It is a new kind of suture designed for use in both skin and deeper structures. The suture is orientated in the opposite direction to the needle. Post-injury, knotless sutures hold tissues together and enhance the natural process of healing. They are commonly used on the skin, internal tissues, organs and blood vessels.
Overall, the technological advancements in sutures is likely to boost the market in the coming years.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
Sales of the knotless surgical sutures market in the USA grew at a CAGR of 2.3% from 2015 to 2022. The USA knotless surgical sutures market contributes around 37.7% revenue share to the global knotless surgical sutures market in 2022, which was valued at USD 465.6 Million.
The surgical suture industry has seen some significant advances in technology in recent years. The use of synthetic materials with outstanding tissue-holding capabilities and lower risk of infection and scarring, suture coatings, braiding technologies, barbed sutures, and novel specialised sutures that are in development are some of the breakthroughs in surgical sutures.
Triclosan-coated polyglactin 910 (Vicryl Plus Antibacterial: Ethicon) has been reported to reduce the prevalence of surgical site infections by 30%. These sutures were discovered to have similar handling and tension forces to those of common suture materials. Despite being relatively non-toxic, triclosan has been known to cause skin rashes and allergic reactions.
The increasing aging population and rising incidence of traffic accidents, trauma, burns, cosmetic, orthopedic, cardiovascular, and other surgical procedures offer significant market potential for surgical sutures.
Accidents can result in significant tissue damage, requiring reconstructive surgeries to restore the affected area's form and function. Knotless surgical sutures play a role in reconstructive procedures by providing precise and secure wound closure, which is essential for successful outcomes. The rise in accident cases can lead to an increased demand for reconstructive surgeries, indirectly driving the demand for knotless surgical sutures.
The market for surgical sutures is anticipated to see certain growth restraints due to the rising adoption of substitute wound closure techniques including skin adhesives and tissue sealants. Manufacturers in the USA market for knotless surgical sutures compete with domestic and international businesses across all of their product lines.
When compared to suturing, a lengthy wound can be stapled in 25–50% less time. If used properly, staples can help reduce tissue stress. Staples are very strong and are excellent for closing wounds that are under significant tension. Staples are also generally painless to remove and offer great wound reversal.
The development of surgical adhesives and sealants has provided an alternative method of wound closure in certain surgical procedures. These products can be used in place of traditional sutures, including knotless surgical sutures, to achieve wound closure. The use of surgical adhesives and sealants may reduce the demand for knotless sutures in specific surgical applications.
The Northeast USA dominated the USA market with a value share of around 29.0% in 2022.
Northeast USA has a high healthcare expenditure, and patients are more willing to spend money on effective treatments for knotless surgical sutures. This trend is driving the growth of the market as more patients seek treatment options that can provide them with required care. The growing prevalence of number of accidents such as road accidents and trauma are driving the demand for surgical sutures in the Northeast state of USA and thereby, increase in the adoption of knotless surgical sutures.
Midwest is projected to be the most attractive market in knotless sutures growing at a CAGR of close to 4.1% over the forecast period.
In the United States, knotless surgical sutures are gaining popularity, especially in the Midwest, where there is an increasing need for quick and affordable surgical sutures. The market is anticipated to rise as Knotless Sutures become more widely used. The Midwest market is predicted to grow quickly as the use of technologies such human tendons and tough gel sutures, which have the potential to considerably boost operating efficiency, grows.
Such futuristic steps and missions are going to escalate Midwest’s knotless surgical sutures market in the projected period.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The absorbable surgical sutures segment held the major chunk of 61.0% of the USA market by the end of 2022.
Absorbable sutures can break down naturally over the time, within the body itself. They eliminate the need for suture removal, which can be beneficial for patients and reduce the risk of complications associated with suture removal procedures.
Absorbable sutures are commonly used for internal tissues that heal relatively quickly or in areas that are difficult to access for suture removal.
Polyglactin absorbable surgical sutures were the predominant segment with a market share of 22.4% in the USA market by the end of 2022.
Polyglactin sutures offer adequate tensile strength, allowing them to hold tissues together during the critical healing period. The sutures maintain their strength for a sufficient duration, providing support until the wound heals. Polyglactin sutures are biodegradable, meaning they break down into biocompatible byproducts that can be metabolized and eliminated by the body. This property eliminates the need for suture removal procedures.
As it is the mostly used raw material, it holds significant market share in the USA market.
The synthetic source segment is accounted for a revenue share of 51.3% in the USA market at the end of 2022.
Synthetic knotless sutures often utilize innovative anchoring mechanisms or self-locking technology to secure the suture in place without the need for knots. These mechanisms can provide reliable and secure closure, minimizing the risk of suture slippage or failure.
The cardiovascular procedures segment accounted for a revenue share of 32.2% in the USA market at the end of 2022.
In cardiac surgery, it is possible to close the right atrium cannulation site with knotless barbed sutures and an extra self-locking technique without any immediate or long-term consequences. This creates opportunities for minimally invasive heart surgery employing knotless barbed sutures. This work demonstrates that barbed knotless sutures effectively close a low-pressure heart structure, which could speed up minimally invasive surgery.
The hospital laboratories accounted for a revenue share of 34.9% in the USA market at the end of 2022.
Hospital laboratories plays a role in evaluating the performance and characteristics of various sutures, including knotless sutures, through testing and research. They might assess factors such as suture strength, biocompatibility, and tissue response. These evaluations can contribute to the understanding and selection of appropriate sutures for surgical procedures.
Among the primary approaches used by organizations to get a competitive edge in the market are new launches, technical advancements, and regulatory compliance, acquisition and distribution agreements with other businesses to expand their business.
For instance:
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in USA knotless surgical sutures market space, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2015 to 2022 |
| Market Analysis | USD Million for Value |
| Key Country Covered | USA |
| Key States Covered | Northeast, Midwest, Southeast, Southwest, West |
| Key Segments Covered | Product, Raw Material, Source, Application End User, and Region |
| Key Companies Profiled | Medtronic; B. Braun Melsungen AG; Teleflex Incorporated; Johnson & Johnson (Ethicon); CONMED Corporation; Corza Medical; CP Medical; DemeTECH Corporation; Sutumed; DSI Dental Solution; Golnit Sutures; Vital Sutures; Atramat; Unilene; Advanced MedTech Solutions Pvt. Ltd; Dolphin Sutures; Arthrex, Inc; GMD Group; Dynek Pvt Ltd; Kono Seisakusho Co.,Ltd); Olimp- Surgical Sutures; Lotus Surgicals; Unisur Lifecare Pvt Ltd. |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is valued at USD 181 million in 2023.
The Market is estimated to develop at a CAGR of 3.6%.
The market is estimated to reach USD 258.7 million by 2033.
The top 5 companies are expected to hold 32.1% of the market.
Healthcare spending, accident rates, and innovation are the key opportunities.
Explore Therapeutic Device Insights
View Reports
USA Knotless Surgical Sutures Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
